Ultragenyx Pharmaceutical Inc. buy Morgan Stanley
Start price
04.08.23
/
50%
€34.60
Target price
04.08.24
€86.28
Performance (%)
30.06%
End price
05.08.24
€45.00
Summary
This prediction ended on 05.08.24 with a price of €45.00. The BUY prediction by Morgan_Stanley for Ultragenyx Pharmaceutical Inc. saw massive gains of 30.06%. Morgan_Stanley has a follow-up prediction for Ultragenyx Pharmaceutical Inc. where he still thinks Ultragenyx Pharmaceutical Inc. is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 4.950% | 4.950% | 44.022% |
| iShares Core DAX® | 1.887% | 1.967% | 17.000% |
| iShares Nasdaq 100 | 2.316% | -1.227% | 22.986% |
| iShares Nikkei 225® | 1.134% | 0.390% | 9.520% |
| iShares S&P 500 | 1.821% | 0.790% | 22.957% |
Comments by Morgan_Stanley for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $95.00 price target on the stock.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€34.40
10.10.23
10.10.23
€84.74
10.10.24
10.10.24
54.07%
17.09.24
17.09.24
Stopped prediction by Morgan_Stanley for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€36.60
03.11.23
03.11.23
€78.49
03.11.24
03.11.24
42.08%
17.09.24
17.09.24